ERBB2 and ductal breast carcinoma in situ: She was diagnosed with invasive carcinoma of the breast of no special type, with associated ductal carcinoma in situ that was progesterone- and estrogen-receptor-positive but negative for human epidermal growth factor receptor 2 (HER2).